[ad_1]
Scientists at the Johns Hopkins Cancer Center have created an "ideal blend" that can eliminate pancreatic cancer. Scientists say that if pancreatic cancer is present, there is a lack of immune T cells, which must identify and eliminate cancer cells.
Today, scientists have identified three drugs to form a perfect combination for the treatment of pancreatic cancer. The researchers say the combination consists of PancVAX, an antibody-enhancing product with anti-PD-1 and OX40 antibody control. After the tests, an increase in the immune response and an increase in the number of T lymphocytes were observed. Trials should begin clinical trials on patients next year.
[ad_2]
Source link
